- Category
- Micro (2020-21)
- Udyam number
- UDYAM-CH-01-0001749

About Inovin Pharmaceuticals Private Limited
Data last updated:
Inovin Pharmaceuticals Private Limited is a private limited company based in Manimajra, Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U74999CH2018PTC042017. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manav Garg and Rishabh Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf No. 265 Second Floor Motor Market, Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.38 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹4.3 Lakh (net margin 1.8%) and EBITDA of ₹12.81 Lakh (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years.
The company is associated with 1 brand: Inovin.
Inovin Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0001749). For more details, the company can be reached via its website inovin.in.
Company details
Recognitions & Rankings of Inovin Pharmaceuticals
Contact details
Inovin Pharmaceuticals Private Limited's registered office is in Manimajra, Chandigarh.
- Registered AddressScf No. 265 Second Floor Motor Market, Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inovin Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Inovin Pharmaceuticals Private Limited, buy the company report.
Financials of Inovin Pharmaceuticals Private Limited
FY 2025 filings availableInovin Pharmaceuticals Private Limited reported revenue of ₹2.38 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 44% over three years, including 14% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹12.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inovin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Inovin Pharmaceuticals Private Limited
Inovin Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manav Garg Also directs: Carenix Bio Pharma Private Limited | Director | 02 Jan 2023 | 3 Years 10 Months | Current |
| Rishabh Garg | Additional Director | 13 Jan 2020 | 6 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Inovin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inovin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Inovin Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Inovin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Inovin Pharmaceuticals Private Limited has 6 board changes on record since 2018: 4 appointments and 2 cessations. The latest: Deepak Kumar Garg ceased to be Director on 02 Jan 2023.
Frequently asked questions
Inovin Pharmaceuticals is an active private limited company based in Manimajra, Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 May 2018 (8+ years old) and is registered under CIN U74999CH2018PTC042017.
Inovin Pharmaceuticals has 2 current directors:
- Manav Garg - Director
- Rishabh Garg - Additional Director
The latest financial statements of Inovin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
No. Inovin Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Inovin Pharmaceuticals is U74999CH2018PTC042017. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inovin Pharmaceuticals was incorporated on 25 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chandigarh.
Deepak Kumar Garg ceased to be Director on 02 Jan 2023. Manav Garg was appointed as Director on 02 Jan 2023. Rishabh Garg was appointed as Additional Director on 13 Jan 2020. Inovin Pharmaceuticals has 6 board changes on record in total.
Yes, Inovin Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-CH-01-0001749).
Inovin Pharmaceuticals can be reached through the website inovin.in. Its registered office is in Manimajra, Chandigarh, India.
The registered office of Inovin Pharmaceuticals is at Scf No. 265 Second Floor Motor Market, Manimajra, Chandigarh, India – 160101.

